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Colistin is an old antibiotic which has been used as a therapeutic option for carbapenem- andmultidrug-resistant Gram-nega-
tive bacteria, like Acinetobacter baumannii. This pathogen produces life-threatening infections, mainly in patients admitted to
intensive care units. Rapid detection of resistance to colistin may improve patient outcomes and prevent the spread of resistance.
For this purpose, Micromax technology was evaluated in four isogenic A. baumannii strains with knownmechanisms of resis-
tance to colistin and in 66 isolates (50 susceptible and 16 resistant). Two parameters were determined, DNA fragmentation and
cell wall damage. To assess DNA fragmentation, cells trapped in a microgel were incubated with a lysing solution to remove the
cell wall, and the released nucleoids were visualized under fluorescence microscopy. Fragmented DNAwas observed as spots that
diffuse from the nucleoid. To assess cell wall integrity, cells were incubated with a lysis solution which removes only weakened
cell walls, resulting in nucleoid release exclusively in affected cells. A dose-response relationship was demonstrated between
colistin concentrations and the percentages of bacteria with DNA fragmentation and cell wall damage, antibiotic effects that
were delayed and less frequent in resistant strains. Receiver operating characteristic (ROC) curves demonstrated that both DNA
fragmentation and cell wall damage were excellent parameters for identifying resistant strains. Obtaining<11% of bacteria with
cell wall damage after incubation with 0.5g/ml colistin identified resistant strains of A. baumanniiwith 100% sensitivity and
96% specificity. Results were obtained in 3 h 30min. This is a simple, rapid, and accurate assay for detecting colistin resistance in
A. baumannii, with strong potential value in critical clinical situations.
Acinetobacter baumannii is a Gram-negative coccobacillus thatsurvives in the hospital niche and has the ability to persist for
long periods on desiccated surfaces (1, 2). This microorganism
predominates in intensive care units (ICUs) and can produce
severe mechanical ventilation-associated pneumonia, central ve-
nous catheter-associated bloodstream infections, and catheter-as-
sociated urinary tract infections as well as infections in the central
nervous system, skin, soft tissues, and bone (2–4).
Worldwide rates of multidrug-resistant A. baumannii strains
are increasing alarmingly, and even panresistance is emerging (5).
For example, 36.8% ofA. baumannii strains isolated from patients
with ventilator-associated pneumonia in the United States are re-
sistant to carbapenems, and resistance rates are as high as 85% in
isolates from intensive care units in Greece. Resistance may also
extend to fluoroquinolones, cephalosporins, etc. (6).
Colistin (polymyxin E), an old polymyxin antibiotic discov-
ered in 1949, has undergone a resurgence in use in recent years as
a therapeutic option for carbapenem- or multidrug-resistant
Gram-negative bacteria (7–12). Polymyxins consist of a hydro-
philic polycationic peptide ring and a tripeptide side chain with a
lipophilic fatty acid tail (13). They are bactericidal antibiotics that
bind to lipopolysaccharides (LPSs) and phospholipids in the outer
cell membrane of Gram-negative bacteria. The polycationic pep-
tide ring has a strong affinity for divalent cations and competi-
tively displaces calcium and magnesium from the negatively
charged phosphate groups of the lipid A of LPSs (14, 15). It alters
the stability of the LPS molecule, leading to disruption of the outer
cell membrane and thus altering cellular permeability. More poly-
myxin molecules are inserted into the outer membrane through
the hydrophobic fatty acyl chain domain, producing a detergent-
like effect that causes transient cracks (15). This results in leakage
of intracellular contents and possibly more uptake of the poly-
myxin, i.e., a self-promoted uptake pathway, resulting in bacterial
death (13).
Resistance to colistin is relatively rare, possibly due to its infre-
quent use in these last 50 years and perhaps also because of its
detergent properties. The majority of the mechanisms of resis-
tance to polymyxins are based on modifications of lipid A of the
LPS, which decrease its net negative charge, thus preventing or
reducing the initial binding. These changes may be associated with
mutations in the PmrA/B two-component system, which increase
the level of expression of the lipid A-modifying phosphoethano-
lamine transferase, PmrC, resulting in the addition of phospho-
ethanolamine to lipid A (16–19). Resistance may also be a conse-
quence of the replacement of lipid A with aminoarabinose, which
requires the products of the ugd and pbg loci (20, 21). Unfortu-
nately, there have recently been several outbreaks of infections
caused by colistin-resistantA. baumannii emerging from Asia (22,
23). The emergence of colistin-resistantA. baumannii is very likely
to have major public health implications, since no novel antibiot-
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ics with activity against Gram-negative bacteria are expected to be
available within the coming years (24). As a consequence, there is
an urgent need to optimize the clinical use of colistin and reduce
the development and spread of resistant strains.
Given the elevated risk of mortality in patients with infections
acquired in the intensive care unit (ICU), early adequate antibiotic
therapy has been shown to significantly improve patient outcomes
and reduce health care costs (8, 25, 26). Standard antibiograms
require nearly 24 h or longer after bacterial isolation and identifi-
cation to provide results. But in these critical clinical situations,
the rapid availability of information regarding resistance to car-
bapenems and colistin may be essential.
In a previously reported study, a simple procedure for the rapid
assessment of resistance to carbapenems and ciprofloxacin in A.
baumannii using Micromax technology was validated (27). In the
case of carbapenems, cells immersed in a microgel on a slide were
incubated with a lysing solution that removes the cell wall only in
those bacteria in which peptidoglycan synthesis has been affected
by the beta-lactam. Thus, only susceptible bacteria release the nu-
cleoid, which is stained and visualized under fluorescence micros-
copy. Unaffected bacteria retain their standard shape (27, 28). For
ciprofloxacin assessment, the lysis procedure removes the cell wall
in all bacteria. Those affected by the quinolone, i.e., with double-
strand DNA breaks as a consequence of DNA gyrase and topo-
isomerase IV trapping, show diffusion of DNA fragments emerg-
ing from the residual central core, whereas resistant strains reveal
only intact nucleoids (29–31).
In addition to carbapenems and quinolones, rapid determina-
tion of resistance of A. baumannii to colistin is of remarkable
interest. It not only has decisive clinical value for patients, it also
could contribute to optimizing the medical use of colistin, thereby
helping to prevent the spread of strains resistant to a last-resort
antibiotic. In this study we characterized the efficacy of using both
DNA damage and cell wall damage assays to rapidly determine the
resistance of A. baumannii to colistin.
MATERIALS AND METHODS
Bacterial strains. The procedures for determining chromosomal DNA
fragmentation and cell wall damage in situwere first assayed for controlA.
baumannii strains harboring known mechanisms of colistin resistance.
These were laboratory isogenic strains derived from susceptible strains
from the American Type Culture Collection (ATCC; Manassas, VA),
ATCC 19606 ColS (MIC, 0.25 g/ml), ATCC 19606 ColR (MIC, 16 g/
ml), ATCC 19606 ColR lpxA (MIC, 32 to 64 g/ml), and ATCC 19606
ColR lpxD (MIC,64 g/ml) (18, 32, 33).
Afterward, 66 A. baumannii isolates obtained from the University
Hospital A Coruña and Virgen del Rocío Hospital, Seville, between 2001
and 2012 were analyzed. Repetitive extragenic palindromic (REP)-PCR
was performed in some cases to rule out clonality (17). All of the isolates
were clinical isolates except for a group of 4 and another group of 5 labo-
ratory-derived isogenic strains. The MICs were determined by automated
microdilution (MicroScan WalkAway; Siemens) repeated a minimum of
6 times. According to the CLSI breakpoint concentration of susceptibility
(2 g/ml), 50 strains were categorized as susceptible (MIC, 2 g/ml),
and 16 were categorized as resistant (MIC,4g/ml) to colistin (five with
an MIC of 4 g/ml, five with an MIC of 8 g/ml, two with an MIC of 16
g/ml, two with an MIC of 32 g/ml, and two with an MIC of 32
g/ml). Of these resistant strains, 10 were laboratory derived and 6 natu-
rally occurring clinical isolates.
DNA damage and cell wall damage assays. Determinations of DNA
fragmentation and cell wall integrity were carried out as blind procedures,
without knowledge of the MICs, by three independent technicians. Two
variants of the Micromax kit for fluorescence microscopy (research use
only) (Halotech DNA SL, Madrid, Spain), Micromax Q and Micromax
WG, have been employed to evaluate the integrity of the nucleoid and of
the cell wall, respectively. Their only difference lies in the composition of
the lysing solution (27).
Bacteria were routinely grown on Mueller-Hinton agar at 37°C for 24
h. A colony was selected and incubated in 2 ml Mueller-Hinton broth at
37°C for 90 min. The bacteria were diluted to an optical density at 600 nm
(OD600) of 0.1 in Mueller-Hinton broth and incubated at 37°C in 200-l
tubes with colistin for 60 min, in a final volume of 30 l. In initial exper-
iments, the four control ATCC 19606 strains were incubated with 11 doses
of colistin ranging from 0 to 64 g/ml. Afterward, the other 66 strains
were treated with colistin concentrations of 0, 0.4, 0.5, 0.75, and 1 g/ml.
An aliquot of each sample was diluted to a concentration of 5 to 10 million
microorganisms/ml in Mueller-Hinton broth. The kit includes 0.5-ml
snap-cap microcentrifuge tubes containing gelled aliquots of low-melt-
ing-point agarose. The tube was placed in a water bath at 90 to 100°C for
about 5 min to melt the agarose completely and then placed in a water
bath at 37°C. Thirty microliters of the diluted sample was added to the
tube and mixed with the melted agarose. A 10-l aliquot of the sample-
agarose mixture was pipetted onto a precoated slide and covered with an
18- by 18-mm coverslip. The slide was placed on a cold plate in the refrig-
erator (4°C) for 5 min to allow the agarose to produce a microgel with the
trapped intact cells inside. The coverslip was removed gently, and the slide
was immediately immersed horizontally in 10 ml of the specific lysing
solution for 5 min at room temperature The slide was washed horizontally
in a tray with abundant distilled water for 3 min, dehydrated by incubat-
ing horizontally in cold (20°C) ethanol of increasing concentrations
(70%, 90%, and 100%) for 2 min each, and air dried in an oven. The dried
slide was incubated in a microwave oven at 750 W for 4 min, and then the
DNA was stained with 100 l of the fluorochrome SYBR gold (Molecular
Probes, Eugene, OR) diluted 1:200 in Tris-borate-EDTA (TBE) buffer
(0.09 M Tris-borate, 0.002 M EDTA [pH 7.5]) for 2 min in the dark, with
a glass coverslip. After a brief wash in phosphate buffer (pH 6.88) (Merck,
Darmstadt, Germany), a 24- by 60-mm coverslip was added. The slides
were visualized under fluorescence microscopy and 200 to 500 bacteria
were scored per experimental point. The scoring criterion of DNA frag-
mentation is the presence of diffused DNA fragments from the nucleoid
(27, 30). Otherwise, cell wall damage is evidenced when the nucleoid is
released (27, 28). The time required for the assay included 1 h 30 min of
incubation of the bacteria in Mueller-Hinton broth, 1 h of incubation
with colistin, 40 min of technical processing (10 min of microgel enclos-
ing, 5 min of lysis, 15 min of washing and dehydrating, and 10 min of
drying and staining), and 5 to 15 min of scoring under the microscope, for
a total of 3 h 15 min to 3 h 30 min.
Statistical analysis. Data were normally distributed as ascertained by
the Kolmogorov-Smirnov test. The Student t test was performed to check
homogeneity. Receiver operating characteristic (ROC) curves were con-
structed for establishing the optimal concentration of colistin to deter-
mine possible resistance and calculate cutoff values for DNA fragmenta-
tion and cell wall damage in predicting resistance to colistin, using the
Youden index (J). Data were analyzed using the IBM SPSS Statistics 21
software package for Windows (IBM). For determination of the Youden
index we used the Epidat 3.1 software package (Consellería de Sanidade,
Xunta de Galicia, Spain, and Panamerican Health Organization, Wash-
ington, DC). Differences were defined as significant at P values of0.05.
RESULTS AND DISCUSSION
The procedures for the determination of DNA fragmentation and
cell wall damage were initially assessed by incubating four isogenic
A. baumannii strains with a high range of concentrations of colis-
tin, from 0 to 64g/ml. In the susceptible strain ATCC 19606 ColS
(MIC, 0.25g/ml), after incubation with the lowest concentration
(0.2 g/ml), 13% of cells showed DNA fragmentation whereas
65% appeared affected at the cell wall. Incubation with the next
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concentration (0.4 g/ml) resulted in 20.5% of cells with DNA
fragmentation and 93% (almost all of them) with cell wall damage
(Fig. 1).
The laboratory-derived colistin-resistant strain ATCC 19606
ColR (MIC, 16 g/ml) possesses a single nucleotide Ala227Val
mutation in pmrB (32) that is adjacent to the conserved histidine
at the site of phosphorylation (His228), which is critical for phos-
phatase activity. The final result is the addition of phosphoetha-
nolamine to hepta-acylated lipid A (18). Although less immuno-
genic than the wild type, this LPS modification confers colistin
resistance. Unlike the parental strain, the mutant strain achieved
only 2.5% of cells with fragmented DNA after incubation with the
FIG 1 Distributions of the frequencies of cells with DNA fragmentation (left) and levels of cell wall damage (right) after incubation with increasing concentra-
tions of colistin of isogenicA. baumannii strains susceptible (ATCC 19606 ColS) and with defined mechanisms of resistance to colistin (ATCC 19606 ColR, ATCC
19606 ColR lpxA, ATCC 19606 ColR lpxD).
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highest concentration of colistin (64g/ml) and 17% of cells with
affected cell walls after incubation with 16 to 64 g/ml (Fig. 1). A
discrete intercellular background of DNA fragments was visual-
ized in the cultures of the susceptible strains at concentrations of
0.4 g/ml and higher when the lysing solution was used to deter-
mine cell wall integrity, but not when lysis was employed to assess
nucleoids. This background was absent in the cultures of the re-
sistant strain.
The isogenic strains ATCC 19606 ColR lpxA (MIC, 32 to 64
g/ml) and ATCC 19606 ColR lpxD (MIC,64g/ml) were also
studied. These laboratory derivatives carry mutations in the genes
implicated in lipid A biosynthesis, lpxA and lpxD, respectively,
leading to loss of LPS production and increased MICs of colistin
(33). After technical processing, even in the absence of the antibi-
otic, these strains evidenced decreased fitness and showed high
intercellular backgrounds of DNA fragments spontaneously re-
leased into the culture medium. This background was maintained
with the lysing solution used to check cell wall damage but tended
to disappear when the stronger lysing solution was used to release
the nucleoids. In both strains, no more than 4 to 4.5% of cells
showed fragmented DNA, and there were no relationships be-
tween the percentages of fragmentation and the doses of colistin
(Fig. 1). Interestingly, the lpxA mutant showed 75 to 80% of cells
with released nucleoids when incubated with the lysing solution to
assess cell wall integrity, without antibiotic and without changes
with increasing concentrations (Fig. 1). This suggests a constitu-
tively weaker cell wall. This spontaneous effect on the cell wall was
also detected in the lpxD mutant strain, but only in 14 to 20% of
FIG2 Box-and-whisker plots of the dose response ofA. baumannii strains susceptible (above) and resistant (below) to colistin, for DNA fragmentation (left) and
for cell wall damage (right). The horizontal line in the box represents the median, the lower line of the box the first quartile, and the upper line of the box the third
quartile data values, and the whiskers (the end of the vertical lines) represent the maximum and minimum data values. The dots outside the box correspond to
abnormally high values.
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cells, also without significant increases with higher concentrations
(Fig. 1). The less resistant cell wall in the lpxA mutant is in accor-
dance with the previously described changes in its membrane po-
tential, which were probably due to effects on outer membrane
integrity and loss of affinity to colistin (34).
It is doubtful that A. baumannii strains without LPS can sur-
vive in nature given their low fitness. Moreover, their possible
virulence should be greatly compromised. In any case, these
strains were detected by the technique to assess cell wall damage,
showing a strong background of DNA fragments and exhibiting
weak cell walls, even in the absence of colistin treatment. Colistin-
resistant strains in nature should be more closely related to ATCC
19606 ColR, which exhibits a modified LPS in the outer cell mem-
brane, than to strains without LPS. Consequently, taking into ac-
count the results with the susceptible ATCC 19606 and the resis-
tant ATCC 19606 ColR strains, the techniques of detection of
DNA fragmentation and cell wall damage appear adequate for
making rapid distinctions between A. baumannii strains suscepti-
ble and resistant to colistin. The cell wall assay seemed especially
discriminative. In a quantitative validation attempt, 66 mostly
clinical strains, 50 susceptible and 16 resistant according to the
CLSI criteria, were studied. MICs were equilibrated and ranged
from 0.03 to32 g/ml.
Figure 2 shows the frequencies of damage to the DNA and the
cell wall after incubation with increasing concentrations of colis-
tin up to 1 g/ml for the susceptible and the resistant strains.
Representative images are presented in Fig. 3 for DNA damage
and in Fig. 4 for cell wall damage for strains with MICs of 0.03 to
0.25, 16, and32g/ml. Unlike the susceptible strains, almost all
of the resistant strains exhibited little damage, and this damage
was evident in only a few cells after incubation at the highest con-
centration. In the susceptible strains, more cells appeared affected
at the cell wall than at the DNA level for each colistin concentra-
tion (Student’s t test, P 0.001). This also occurred in the resis-
tant strains after incubation with colistin concentrations of 0.75
g/ml (P 0.002) and 1 g/ml (P 0.001).
Previously reported studies evaluating this technology were fo-
cused on antibiotics whose primary target was the DNA, like quin-
olones, which produce DNA fragmentation (27, 30), or the cell
wall, like beta-lactams, which inhibit peptidoglycan synthesis
(28). In those cases results were qualitative, affected versus not
affected, since practically the whole population appeared dam-
aged or not. Moreover, the data regarding susceptibility had been
obtained after incubation of the bacteria with the CLSI breakpoint
concentration for susceptibility. In the case of colistin, neither the
DNA nor the cell wall is the primary target of the antibiotic. Nev-
FIG 3 Three representative clinical strains of A. baumannii, incubated with colistin for 60 min at 0g/ml (first column, a, d, and g), 0.5g/ml (second column,
b, e, and h), and 1 g/ml (third column, c, f, and i). Bacteria were processed to determine DNA fragmentation evaluated through diffusion of DNA spots from
the nucleoids after technical processing. First row (a, b, and c), susceptible strain 1380 (MIC, 0.03 to 0.25 g/ml); second row (d, e, and f), strain 1384 (MIC, 16
g/ml); third row (g, h, and i), resistant strain 1382 (MIC,32 g/ml). Fragmentation of the nucleoids was visualized in the susceptible 1380 strain after 0.5
g/ml (40% of affected cells) and 1 g/ml (80% of affected cells). Only 21% of affected cells were scored after 1 g/ml in the 1384 strain. Nucleoids practically
always appeared intact in the highly resistant 1382 strain (2% of affected cells after 1 g/ml).
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ertheless, DNA fragmentation and cell wall damage were evi-
denced, and these occurred only in a fraction of cells which in-
creased with colistin concentration. This damage should be
secondary, after the primary effect on lipid A and disruption of the
cell membrane with subsequent alteration of permeability (13–
15). One possibility is that the DNA and cell wall damages are
collateral to the production of large amounts of reactive oxygen
species (ROS) during the cell death process, as reported after treat-
ment with bactericidal antibiotics like beta-lactams or quinolones
(35). Given the quantitative nature of this damage in the popula-
tion, even resistant strains may show a fraction of cells affected at
the DNA and/or the cell wall when incubated with concentrations
corresponding to the CLSI breakpoints for resistance. Better dis-
crimination between susceptible and resistant strains could be
achieved when incubating with lower concentrations, which pro-
duce damaged cells at much higher frequencies in the susceptible
than in the resistant strains.
Since the foremost goal of the rapid test was to confidently
identify resistant strains, the concentrations of colistin and the cell
wall damage rates or DNA damage frequencies which optimally
distinguish resistant from susceptible strains were investigated.
For this purpose, we calculated ROC curves for each dose and
analyzed the data with the aim of obtaining a 0% false-negative
rate, because the most undesirable situation is to administer the
antibiotic to a patient infected with a resistant strain, wrongly
identified by the rapid test as susceptible. The ROC curves were
excellent for every dose of colistin assayed, but incubation with a
concentration of 0.5 g/ml was found to be the most discrimina-
tive, with similar values of areas under curve for DNA fragmenta-
tion and for cell wall damage, 0.998  0.003(P  0.0001) (95%
confidence interval [CI] for DNA damage, 0.993 to 1.000; 95% CI
for cell wall damage, 0.991 to 1.000). The optimal cutoff values
were 8.5% and 11% for DNA fragmentation and for cell wall dam-
age, respectively. This resulted in the desirable 0% false-negative
rate in both cases, i.e., 100% sensitivity (95% CI for both DNA
damage and cell wall damage, 0.969 to 1.000). Moreover, the false-
positive rate, i.e., for a susceptible strain which the test identifies as
resistant, was 10% for DNA fragmentation and only 4% for cell
wall damage, i.e., 90% and 96% specificity, respectively (95% CI
for DNA damage, 0.807 to 0.993; 95% CI for cell wall damage,
0.896 to 1.000). Thus, the Youden index (J) values were 0.90 and
0.96 for DNA fragmentation and for cell wall damage, respectively
(95% CI for DNA damage, 0.82 to 0.98; 95% CI for cell wall dam-
age, 0.91 to 1.01).
FIG 4 Three representative clinical strains of A. baumannii, incubated with colistin for 60 min at 0g/ml (first column, a, d, and g), 0.5g/ml (second column,
b, e, and h), and 1g/ml (third column, c, f, and i). Bacteria were processed to determine effects on the cell wall evaluated through nucleoid release after technical
processing. First row (a, b, and c), susceptible strain 1380 (MIC, 0.03 to 0.25 g/ml); second row (d, e, and f), strain 1384 (MIC, 16 g/ml); third row (g, h, and
i), resistant strain 1382 (MIC,32g/ml). Release of the nucleoids was obvious in the susceptible 1380 strain after 0.5g/ml (41% of affected cells) and 1g/ml
of colistin (100% of affected cells), but with lower frequency after 1g/ml in the 1384 strain (31% of affected cells). A discrete background of extracellular DNA
fragments was visualized in the colistin-affected cultures.A. baumannii bacteria of the highly resistant 1382 strain almost always maintained their morphological
appearance (2% of affected cells after 1 g/ml).
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In conclusion, both DNA fragmentation and cell wall damage
are excellent parameters for discriminating susceptible and resis-
tant strains, but the latter assay appears to be more specific. Ob-
taining 11% of bacteria with cell wall damage after incubation
with 0.5 g/ml colistin identifies resistant strains of A. baumannii
with 100% sensitivity and 96% specificity according to CLSI stan-
dards. The assay requires 1 h of incubation with colistin concen-
trations of 0 and 0.5 g/ml, 40 min of technical processing, and 5
to 15 min of scoring of 200 to 500 cells, a total of approximately 2
h. If the bacteria were not exponentially growing, 90 min of pre-
vious incubation in Mueller-Hinton broth is desirable in order to
achieve exponential growth before the subsequent addition of
colistin. This also eliminates the possible background of cells with
fragmented DNA and cell wall damage in the control 0 g/ml
dose. Taking this into account, the results could be available in 3 h
30 min. Simultaneous processing of a control susceptible and a
control resistant strain is adequate for validation of results. In
comparison with the routine automatic microdilution procedure,
the present methodology is much faster, 3 h 30 min versus 6 to 8 h,
and allows a cell-by-cell assessment, so heterogeneity in damage
induction and evolution with time, heteroresistance, or related
phenomena could possibly be ascertained. Otherwise, the meth-
odology is manual or semiautomatic and requires an epifluores-
cence microscope, as well as cell scoring. The latter can be easily
automated through a motorized microscope coupled with a digi-
tal camera and image analysis software. Finally, the testing is re-
stricted to colistin and a few other antibiotics previously validated
(27, 28, 30, 31), unlike the commercial microdilution panels
which evaluate 15 to 20 antibiotics. Nevertheless, more antibiotics
will be assayed and validated in the future, for incorporation into
the Micromax assay.
This is a rapid, simple, and reliable procedure for determining
resistance to a relevant antibiotic like colistin in clinical A. bau-
mannii strains. This may help facilitate the administration of early
adequate antibiotic therapy in cases of life-threatening infections
caused by A. baumannii and promote the responsible use of this
therapeutic option, preserving it and avoiding the spread of resis-
tances.
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